Issue 4March 2016
Special report

Intestinal Microbiota, Obesity, and Associated Metabolic Disorders

Download for free


    The many studies conducted on microbiota in recent years have shown how important they are for our physiology and how issues with microbiota play a role in many diseases. We owe this plethora of studies to the work of Jeffrey Gordon and his team who showed a decade ago that mice without gut microbiota had less adipose tissue and that obese individuals had different microbiota than thin individuals.

    Thus, the hypothesis that gut microbiota could be involved in obesity came to be. Numerous studies have since confirmed the contribution of gut microbiota to obesity and its metabolic comorbidities such as type 2 diabetes and fatty liver disease. This issue aims to take stock of this topical subject, given the growing prevalence of these conditions and the hope of developing targeted treatments of the gut microbiota.

    Table of contents

    • Special Report

      • The Non-Selective Effect of Selective Digestive Decontamination
        Scientific committee : Philippe Gérard
    • The Microbiota Chronicle

      • The Non-Selective Effect of Selective Digestive Decontamination
        Scientific committee : Bruno Pot
      • Diverticulitis: Gut Microbiota Not Responsible
        Scientific committee : Bruno Pot
      • Microbiota of the Meconium: The Earliest Gut Microbiota
        Scientific committee : Alexis Mosca
      • Faecal Microbiota Transplantation and IBS with Bloating
        Scientific committee : Stanislas Bruley des Varannes
      • Benefits of Early Probiotic Supplements for Children to Limit the Risk of Developing an Allergy
        Scientific committee : Jean-Marc Bohbot
      • Gut Microbiota and HIV
        Scientific committee : Jacques Amar
    • Microbiota News

    • Interview

      • Patrice D. Cani
        Contributors :
    • In Brief

    • Focus

    • Taxonomic Reference

    Scientific committee

    These other issues may interest you